Long‐term cancer outcomes after bariatric surgery
Obesity · 2023-09 · 31 (9) · 2386-2397
DOI: 10.1002/oby.23812 ↗At a glance
Journal article in Obesity, published online on 2023-08-22. Written by Ted D Adams and 11 co-authors. Institution: Intermountain Surgical Specialties/Digestive Health Clinical Program, Intermountain Healthcare, Salt Lake, Utah, USA. Major MEDLINE topics: Bariatric Surgery, Neoplasms. Cited 29 times so far (Crossref); 42 references. The full text is freely available in PubMed Central. Funded by: NIDDK NIH HHS, Intramural NIH HHS, NCI NIH HHS.
Abstract (original language)
Objective
Obesity is associated with increased cancer risk. Because of the substantial and sustained weight loss following bariatric surgery, postsurgical patients are ideal to study the association of weight loss and cancer.
Methods
Retrospectively (1982–2019), 21,837 bariatric surgery patients (surgery, 1982–2018) were matched 1:1 by age, sex, and BMI with a nonsurgical comparison group. Procedures included gastric bypass, gastric banding, sleeve gastrectomy, and duodenal switch. Primary outcomes included cancer incidence and mortality, stratified by obesity‐ and non‐obesity‐related cancers, sex, cancer stage, and procedure.
Results
Bariatric surgery patients had a 25% lower risk of developing any cancers compared with a nonsurgical comparison group (hazard ratio [HR] 0.75; 95% CI 0.69–0.81; p < 0.001). Cancer incidence was lower among female (HR 0.67; 95% CI 0.62–0.74; p < 0.001) but not male surgery patients, with the HR lower for females than for males ( p < 0.001). Female surgery patients had a 41% lower risk for obesity‐related cancers (i.e., breast, ovarian, uterine, and colon) compared with nonsurgical females (HR 0.59; 95% CI 0.52–0.66; p < 0.001). Cancer mortality was significantly lower after surgery in females (HR 0.53; 95% CI 0.44–0.64; p < 0.001).
Conclusions
Bariatric surgery was associated with lower all‐cancer and obesity‐related cancer incidence among female patients. Cancer mortality was significantly lower among females in the surgical group versus the nonsurgical group.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Intermountain Surgical Specialties/Digestive Health Clinical Program, Intermountain Healthcare, Salt Lake, Utah, USA.
- Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake, Utah, USA.
- Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake, Utah, USA.
- Utah Population Database, University of Utah, Salt Lake, Utah, USA.
- Department of Exercise Sciences, Brigham Young University, Provo, Utah, USA.
- Intermountain Biorepository, Intermountain Healthcare, Salt Lake, Utah, USA.
ORCID profiles: Ted D Adams, Lance E Davidson, Mary Playdon, Sheetal Hardikar
Funding
- NIDDK NIH HHS
- Intramural NIH HHS
- NCI NIH HHS
- NCRR NIH HHS
- Johnson and Johnson
- National Institute of Diabetes and Digestive and Kidney Diseases
- U.S. Public Health Service
Cite
APA
Adams, T. D., Meeks, H., Fraser, A., Davidson, L. E., Holmen, J., Newman, M., Ibele, A. R., Playdon, M., Hardikar, S., Richards, N., Hunt, S. C., & Kim, J. (2023). Long‐term cancer outcomes after bariatric surgery. Obesity, 31(9), 2386-2397. https://doi.org/10.1002/oby.23812
Vancouver
Adams TD, Meeks H, Fraser A, Davidson LE, Holmen J, Newman M, et al. Long‐term cancer outcomes after bariatric surgery. Obesity. 2023;31(9):2386-2397. doi:10.1002/oby.23812
BibTeX
@article{Adams2023,
author = {Adams, Ted D and Meeks, Huong and Fraser, Alison and Davidson, Lance E and Holmen, John and Newman, Michael and Ibele, Anna R and Playdon, Mary and Hardikar, Sheetal and Richards, Nathan and Hunt, Steven C and Kim, Jaewhan},
title = {Long‐term cancer outcomes after bariatric surgery},
journal = {Obesity},
year = {2023},
volume = {31},
number = {9},
pages = {2386--2397},
doi = {10.1002/oby.23812}
}
EUVIMED